Israel HealthCare Ventures

Venture Capital Tel Aviv-Yafo, Israel Est. 2000
Visit website ↗ LinkedIn
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

Israel HealthCare Ventures (IHCV) is an Israeli life sciences venture fund. To date, IHCV I and IHCV II have cumulatively invested approximately $135 million in 27 companies. IHCVs portfolio includes companies in medical fields including cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, central nervous system, and others. It covers therapeutic and diagnostic technologies as well as rehabilitation, drug delivery, and consumer healthcare. About 75% of the funds portfolio consists of medical device companies, with the rest in pharmaceuticals and biotechnology. IHCV is a venture fund that operates much like a long-term investment company. It pursues a hands-on, personal, and informal approach, providing portfolio companies with professional advice, ongoing management support, and an extensive network of contacts throughout the global medical and financial arenas. The fund is not limited by preset policies that define the stage, discipline, or size of investment.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Israel HealthCare Ventures' primary investment focus?
Israel HealthCare Ventures (IHCV) is an Israeli life sciences venture fund. Approximately 75% of its portfolio consists of medical device companies, with the remainder in pharmaceuticals and biotechnology.
How much capital has Israel HealthCare Ventures cumulatively invested?
To date, Israel HealthCare Ventures (IHCV) I and IHCV II have cumulatively invested approximately $135 million across 27 companies.
Can you name some notable portfolio companies of Israel HealthCare Ventures?
Notable portfolio companies include Gamida Cell, which had a Public Offering in October 2018, and Optonol, which was acquired by Alcon in December 2009.
What is Israel HealthCare Ventures' approach to supporting its portfolio companies?
Israel HealthCare Ventures (IHCV) operates with a hands-on, personal, and informal approach, providing professional advice, ongoing management support, and an extensive network of contacts in the global medical and financial arenas.
What is the range of investment amounts for Israel HealthCare Ventures?
Israel HealthCare Ventures' investment range is between $500K and $20M per investment.
When was Israel HealthCare Ventures founded?
Israel HealthCare Ventures was founded in 2000.
Has Israel HealthCare Ventures led any investment rounds?
Yes, Israel HealthCare Ventures led an investment round for GI-View in December 2014 with an amount of $13 million, and for Candela in January 2002.
What types of medical fields does Israel HealthCare Ventures' portfolio cover?
Israel HealthCare Ventures' portfolio covers medical fields such as cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, and central nervous system, among others. It also includes therapeutic and diagnostic technologies, rehabilitation, drug delivery, and consumer healthcare.